Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study

Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study

Objectives: Although chemotherapy-induced congestive heart failure (CHF) is a well-known adverse event in cancer survivors, the long-term risk of standard low-dose anthracycline has not yet been reported. This study aimed to investigate the long-term effects of standard anthracycline on late CHF in...

Full description

Bibliographic Details
Main Authors: Il Yong Chung, Jong Won Lee, Hyeong-Gon Moon, Kyung Hwan Shin, Wonshik Han, Byung Ho Son, Sei-Hyun Ahn, Dong-Young Noh
Format: Article
Language:English
Published: Elsevier 2020-10-01
Series:Breast
Subjects:
Breast neoplasms
Chemotherapy
Adjuvant
Anthracyclines
Heart failure
Cancer survivors
Online Access:http://www.sciencedirect.com/science/article/pii/S096097762030148X

Internet

http://www.sciencedirect.com/science/article/pii/S096097762030148X

Similar Items